Followers | 139 |
Posts | 6806 |
Boards Moderated | 0 |
Alias Born | 03/20/2012 |
Tuesday, April 27, 2021 11:28:21 PM
I was thinking about the same thing. Where would this leave the licensing agreement with Oncology Phama if another company swoops in to buy out and take over Regen BioPharma?
And does it even make any sense that David Koos would have struck a deal with Oncology Pharma if he was going to just turnaround and negotiate terms with another 3rd party corporation to sell off Regen? In a short answer... It doesn't!
So it makes sense to me as well that maybe there are talks with Oncology Pharma to do a merger type of deal.
But then that brings up the question... Why the 8-K today that shows there is a need to prevent a hostile takeover? It could be that there is a company out there that is trying to do just that so there was a scramble to come up with a poison pill consisting of the new NC Preferred Shares putting Koos in ultimate control of the situation, or maybe it is unknown whether or not there is another entity buying up the company common shares with a takeover in mind and the new preferred shares were drawn up to be used only as a safeguard and precautionary measure.
But I'm leaning towards the idea that THERE IS a company who is trying to make a bid to takeover Regen and Koos put himself and the company in the power position to force another bigger company to have to negotiate a deal with Koos. And from the language in the 8-K today I would say that Koos is definitely "open" to the idea of selling Regen or he wouldn't have stated things the way he did.
So where does that leave the licensing deal that has already been executed with Oncology Pharma?
I believe the simple answer to that would be that part of the terms to sell the rights and ownership of Regen BioPharma to another 3rd party would be the stipulation that the deal with Oncology Pharma would have to be honored and remain in place after a sale is completed. But I'm not an attorney so don't really know all the answers and that would just be my thoughts of how something like that could be included in a new deal.
But if Regen BioPharma is the subject of a possible buy out deal, I hope it's either a merger type of deal with Oncology Pharma or if an interested 3rd party becomes involved, that it be a big pharma company like Pfizer or Eli Lilly, etc... And NOT some stupid hedge fund institutional investor who is buying up a bunch of shares to try and wrestle away control of Regen to try and do a deal with another 4th party entity themselves. That's where things could really get complicated.
It will be very interesting to see how all this plays out, but I'm very hopeful that whatever happens here will be very beneficial to all of us retail common shareholders of $RGBP!
Blessing and best wishes,
LoveAndLight
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM